Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) -15.97-16.8858.1714.65-4.72

What is the latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL is -15.97 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar2024-15.97
Mar2023-16.88
Mar202258.17
Mar202114.65
Mar2020-4.72

How is EV/Core EBITDA of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Core EBITDA % Change
Mar2024 -15.97
Negative
Mar2023 -16.88
Negative
Mar2022 58.17
297.06
Mar2021 14.65
Positive
Mar2020 -4.72 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Core EBITDA ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹286.9 Cr -3.7% -24.6% 96.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,466.0 Cr -3% -6.8% -11.3% Stock Analytics
DIVIS LABORATORIES ₹162,423.0 Cr -0.5% -8.4% 25.1% Stock Analytics
CIPLA ₹128,405.0 Cr -0.2% 1% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,448.0 Cr -3.4% -5.6% 6.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,408.0 Cr -1.1% -2.9% -9.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-3.7%

-24.6%

96.7%

SENSEX

-2.7%

-1.3%

-2.3%


You may also like the below Video Courses